Delivery Order SPE2DB24D2100-SPE2DB25FBDDG

Award Date 3/31/25
Potential Completion Date 4/1/25
Potential Value $9.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Indocin 50 mg suppositories to the Defense Logistics Agency (DLA). The $11,783.82 Delivery Order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on May 10, 2023. The contract has a firm fixed price and an ultimate completion date of May 11, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. The...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $40,855.38 firm fixed-price delivery order covers the procurement of INDOCIN 50 MG SUPPOSITORY 30S, a pharmaceutical product. The contract has an ultimate completion date of April 4, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
The Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,667,233 Indomethacin 50 mg suppositories. The contract, which does not have a set-aside designation, has a completion date of February 15, 2024 and a potential value of $7,956.19. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,172.28, is for the delivery of 4566942443 INDOMETHACIN 1 MG VIALS. The contract is a Firm Fixed Price Delivery Order with a completion date of January 9, 2025. The contract is not designated with a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,710.47, is for the delivery of 4566996332 Indomethacin 25mg capsules. The contract is a Firm Fixed Price Delivery Order with a period of performance through January 22, 2025. The contract was not set aside for any specific business type. Amerisourcebergen Drug Corp holds a larger $999,999,999 Indefinite Delivery Contract (IDC)...
This is a federal contract award by the Defense Logistics Agency (DLA) to the pharmaceutical distributor Amerisourcebergen Drug Corp. The $4,962.55 fixed-price delivery order is for the supply of 237 milliliters of the medication Indomethacin 25 mg/5 ml suspension. The contract has a completion date of May 21, 2025. Amerisourcebergen Drug Corp is the prime contractor and holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX. This IDC...
The Defense Logistics Agency Troop Support Medical awarded a $51,720 delivery order to Amerisourcebergen Drug Corporation for 100 capsules of 25 mg indomethacin. The firm fixed price order is for product delivery to a location in Conshohocken, Pennsylvania by August 2, 2023 with performance beginning on August 1. DLA Troop Support Medical supports the health care needs of military personnel through its Prime Vendor program, and this order is likely placed under an existing...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,934.72, is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. The IDC, valued at $999,999,999, serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
This contract award is for the delivery of ANUCORT-HC 25 MG SUPPOSITORY 12S to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract has a ceiling value of $1,687.87 and is a firm fixed-price delivery order. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,171.50, is a delivery order with a firm fixed price pricing type and an ultimate completion date of January 31, 2025. The contract provides for the delivery of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
  • SPE2DB24D2100
    Indefinite Delivery Contract
  • SPE2DB24D2100-SPE2DB25FBDDG
    Delivery Order

This federal contract award is for the delivery of INDOCIN 50 MG SUPPOSITORY 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $9,100.00, is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp, a major pharmaceutical distributor, with the DLA Troop Support Medical. The IDC, valued at $999,999,999, serves as a vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has a firm fixed-price pricing type and an ultimate completion date of April 1, 2025. The contract does not have a set-aside designation, indicating open competition.

Generated 6/30/25, 10:52 AM